4,003 Shares in Azenta, Inc. (NASDAQ:AZTA) Bought by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. acquired a new stake in Azenta, Inc. (NASDAQ:AZTA) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 4,003 shares of the company’s stock, valued at approximately $200,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC raised its stake in shares of Azenta by 20.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock valued at $74,000 after buying an additional 256 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its holdings in shares of Azenta by 150.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock worth $84,000 after acquiring an additional 955 shares in the last quarter. Net Worth Advisory Group acquired a new position in Azenta in the third quarter worth $205,000. Aigen Investment Management LP acquired a new position in shares of Azenta during the third quarter valued at $214,000. Finally, Sanctuary Advisors LLC acquired a new position in Azenta during the 2nd quarter valued at about $222,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, Director William L. Cornog acquired 12,500 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The shares were acquired at an average price of $39.60 per share, with a total value of $495,000.00. Following the acquisition, the director now owns 14,755 shares of the company’s stock, valued at approximately $584,298. This trade represents a 554.32 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO John Marotta acquired 12,717 shares of Azenta stock in a transaction that occurred on Monday, November 18th. The shares were purchased at an average cost of $39.48 per share, with a total value of $502,067.16. Following the purchase, the chief executive officer now owns 99,612 shares of the company’s stock, valued at $3,932,681.76. This represents a 14.63 % increase in their position. The disclosure for this purchase can be found here. Insiders sold a total of 1,423 shares of company stock worth $57,020 over the last quarter. Insiders own 10.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Needham & Company LLC reduced their target price on Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a report on Wednesday, November 13th. Evercore ISI cut their price target on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 1st. Finally, Stephens restated an “overweight” rating and set a $60.00 price objective on shares of Azenta in a report on Thursday, January 2nd. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, Azenta currently has a consensus rating of “Moderate Buy” and an average target price of $61.60.

Azenta Price Performance

Azenta stock opened at $54.16 on Friday. The business has a 50 day moving average of $48.89 and a 200-day moving average of $49.08. Azenta, Inc. has a 1 year low of $38.82 and a 1 year high of $67.86. The company has a market capitalization of $2.47 billion, a P/E ratio of -18.24 and a beta of 1.47.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.10 by $0.08. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The company had revenue of $170.00 million for the quarter, compared to analyst estimates of $169.66 million. During the same period in the prior year, the firm posted $0.13 EPS. The company’s quarterly revenue was down 1.2% on a year-over-year basis. Equities analysts anticipate that Azenta, Inc. will post 0.41 EPS for the current year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.